Literature Cited

Bergquist NR, Leonardo LR, Mitchell GF. 2005. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integratedapproach? Trends in Parasitology 21:112-7.

Brady MA, Hooper PJ, Ottesen EA. 2006. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends in Parasitology 22: 285-91.

Brooker S, Guyatt H, Omumbo J, Shretta R, Drake L, Ouma J. 2000. Situation analysis of malaria in school-aged children in Kenya: what can be done?. Parasitology Today 16: 183-6.

Brooker S, Beasley M, Ndinaromtan M, Madjiouroum EM, Baboguel M, Djenguinable E, Hay SI, Bundy DA. 2002. Use of remote sensing and a geographical information system in a national helminth control programme in Chad. Bulletin of the World Health Organization 80: 783-9.

Brooker S, Kabatereine NB, Myatt M, Russell Stothard J, Fenwick A. 2005. Rapid assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the Lot Quality Assurance Sampling method in Uganda. Tropical Medicine and International Health 10: 647-58.

Brooker S, Clements AC, Bundy DA. 2006. Global epidemiology, ecology and control of soil-transmitted helminth infections. Advances of Parasitology 62: 221-61.

Bundy DAP, Lwin S, Osika JS, McLaughlin J, and Pannenborg CO. 2000. What should schools do about malaria? Parasitology Today 16: 181-2.

Clarke S, Brooker S, Njagi K, Njau E, Estambale B, Muchiri E, Magnussen P. 2004. Malaria morbidity amongst schoolchildren living in two areas of contrasting transmission in western Kenya. American Journal of Tropical Medicine and Hygiene 71: 732-8.

Clements AC, Lwambo NJ, Blair L, Nyandindi U, Kaatano G, Kinung’hi S, Webster JP, Fenwick A, Brooker S. 2006. Bayesian spatial analysis and disease mapping: tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania. Tropical Medicine and International Health 11: 490-503.

Druilhe P, Tall A, Sokhna C. 2005. Worms can worsen malaria: towards a new means to roll back malaria. Trends in Parasitology 21: 359-62.

Feachem R, Sabot OJ. 2006. An examination of the Global Fund at 5 years. Lancet 368: 537-40.

Fenwick A. 2006. New initiatives against Africa’s worms. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100: 200-7.

Fenwick A, Molyneux D, Nantulya V. 2005. Achieving the Millennium Development Goals. Lancet 365: 1029-30.

Fernando SD, Gunawardena DM, Bandara MRSS, de Silva D, Carter R, Mendis KM, Wickremasinghe AR. 2003. The impact of repeated malaria attacks on the school performance of children. American Journal of Tropical Medicine and Hygiene 69: 582-8.

Fincham JE, Markus MB, Adams V. 2003. Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic. Acta Tropica 86: 315-33.

Foreign Operations, Export Financing, and Related Programs Appropriations Act, 2006 (Enrolled as Agreed to or Passed by Both House and Senate)[H.R.3057.ENR] : SEC. 593:Of the funds appropriated under the heading `Child Survival and Health Programs Fund', not less than $15,000,000 shall be made available to support an integratedresponse to the control of neglected diseases including intestinal parasites, schistosomiasis, lymphatic filariasis, onchocerciasis, trachoma and leprosy: Provided, That the Administrator of the United States Agency for International Development shall consult with the Committees on Appropriations, representatives from the relevant international technical and nongovernmental organizations addressing the specific diseases, recipient countries, donor countries, the private sector, UNICEF and the World Health Organization: (1) on the most effective uses of such funds to demonstrate the health and economic benefits of such an approach; and (2) to develop a multilateral, integratedinitiative to control these diseases that will enhance coordination and effectiveness and maximize the leverage of United States contributions with those of other donors: Provided further, That funds made available pursuant to this section shall be subject to the regular notification procedures of the Committees on Appropriations.

Gallagher M, Malhotra I, Mungai PL, Wamachi AN, Koko JM et al. 2004. The effects of maternal helmnth and malaria infections on mother-to-child HIV transmission. AIDS 19: 1849-55.

Gandhi M. 1906. Indian Opinion, June 2. Quoted in Fischer L. The Essential Gandhi 1962; Vintage Books, p. 326.

Greenwood B. 2006. Review: intermittent preventive treatment – a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Tropical Medicine and International Health 11: 983-91.

Greenwood BM, Bojang K, Whitty CJ, Targett GA. 2005. Malaria Lancet 365: 1487-98.

High-Level Forum on the Health MDGs. 2004. Addressing Africa’s Health Workforce Crisis: An Avenue for Action, Abuja.

Hotez PJ. 2004. The National Institutes of Health roadmap and the developing world. Journal of Investigative Medicine 52: 246-7.

Hotez PJ. 2001. Vaccines as instruments of foreign policy. EMBO reports 2: 862-8.

Hotez PJ. 2006. The “biblical diseases” and U.S. vaccine diplomacy. Brown World Affairs Journal Winter/Spring 12: 247-58.

Hotez PJ, Ferris MT. The antipoverty vaccines. Vaccine 2006; 24: 5787-99.

Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Buss P. 2005. Hookworm: “the great-infection of mankind.” PLoS Medicine 2: e67.

Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Diemert D, Loukas A. 2006a. New technologies for the control of human hookworm infection. Trends in Parasitology 22: 327-31.

Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao SH. 2004. Hookworm infection. New England Journal of Medicine 351: 799-807.

Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. 2006b. Incorporating a rapid impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Medicine 3: e102.

Hotez PJ, Ottesen E, Fenwick A, Molyneux D. 2006c. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Advances in Experimental Medicine and Biology 582: 23-33.

Hotez P, Stoever K, Fenwick A, Molyneux D, Savioli L. 2006d. The Lancet’s chronic diseases series. Lancet 367: 563-4.

Igietseme JU, Eko FO, Black CM. 2003. Contemporary approaches to designing and evaluating vaccines against Chlamydia. Expert Review of Vaccines 2: 129-46.

Kumaresan J. 2005. Can blinding trachoma be eliminated by 20/20? Eye 19:1067-73.
Lammie PJ, Fenwick A, Utzinger J. 2006. A blueprint for success: integration of neglected tropical disease control programs. Trends in Parasitology 22: 313-21.

Lustigman S, James ER, Tawe W, Abraham D. 2002. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends in Parasitology 18: 135-41.

Molyneux DH. 2006. Elimination of transmission of lymphatic filariasis in Egypt. Lancet 367: 966-8.

Molyneux DH, Nantulya HM. 2004. Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals. BMJ 328: 1129-32.

Molyneux DH, Hotez PJ, Fenwick A. 2005. “Rapid impact” interventions: How a policy of integratedcontrol for Africa’s neglected tropical diseases could benefit the poor. PLoS Medicine 2: e336.

Morel CM, Acharya T, Broun D, Dangi A, Elias C, Ganguly NK, Gardner CA, Gupta RK, Haycock J, Heher AD, Keusch GT, Hotez PJ, Krattiger AF, Kreutz FT, Lall S, Lee K, Mahoney R, Martinez-Palomo A, Mashelkar RA, Matlin S, Min HK, Mzimba M, Oehler J, Pick W, Ridley RG, Senanayake P, Singer P, Yun MY. 2005. Health innovation: the neglected capacity of developing countries to address neglected diseases. Science 309: 401-4.

Murray CJL. 1996. Rethinking DALYs. In: The Global Burden of Disease (Murray CJL and Lopez AD, eds.), Global Burden of Disease and Injury Series, Harvard School of Public Health on behalf of the WHO and World Bank, Harvard University Press.

Pecoul B, Chirac P, Trouiller P, Pond J. 1999. Access to essential drugs in poor countries: a lost battle? Journal of the American Medical Association 281: 361-7

Polack S, Brooker S, Kuper H, Mariotti S, Mabey D, Foster A. 2005. Mapping the global distribution of trachoma. Bulletin of the World Health Organization 83: 913-9.

Raso G, Luginbuhl A, Adjoua CA, Tan-Bi NT, Silue KD, et al. 2004. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote dIvoire. International Journal of Epidemiology 33: 1092-1102.

Richards, Jr, Frank O, Abel Eigege, Emmanuel S. Miri, MY Jinadu, and Donald R Hopkins. “Integration of mass drug administration programmes in Nigeria: the challeneges of schistosmoiasis.” Bulletin of the World Health Organization. 2006; 84:673-676. http://www.who.int/bulletin/volumes/84/8/06-029652.pdf (15 September 2006).

Sachs JD, Hotez PJ. 2006. Stepping up the fight against tropical diseases. Science 211: 1521.

Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, Duke M, Don TA, McManus DP, Correa-Oliveira R, Loukas A. 2006. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nature Medicine 12: 835-40.

United States Agency for International Development. 2003. The Health Sector Human Resource Crisis in Africa: an Issues Paper.

Wiesel, E. 1978. A Jew Today Vintage Books (translated by Wiesel M), p. 217

World Health Organization. 2005. Deworming for health and development. Report of the third global meeting of the partners for parasite control, Geneva: World Health Organization.

Xiao SH, Hui-Ming W, Tanner M, Utzinger J, Chong W. 2005. Tribendimidine: a promising, safe and broad-spectrum anthlemintic agent from China. Acta Tropica 94: 1-14.